Finland Studying Genetics of Narcolepsy in Children Receiving GSK's Pandemic Flu Vaccine | GenomeWeb

Originally published Feb. 22.

The Finnish government will be investigating whether there are genetic causes for why 60 children and adolescents from 2009 and 2010 experienced narcolepsy after being vaccinated with GlaxoSmithKline's Pandemrix.

In an interim report released earlier this month, the National Narcolepsy Task Force wrote that due to a "joint effect of the vaccine and some other factors" Pandemrix vaccination "probably" contributed "to the observed increase in [the] incidence of narcolepsy among those four to 19-years of age."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.